Portfolio

deepull secures oversubscribed €50 million Series C financing to advance UllCORE diagnostic system for direct-from-blood rapid pathogen detection April 30, 2025
Accure Therapeutics awarded a total of $1.6M in grants from The Michael J. Fox Foundation and Fonds National de Recherche de Luxembourg to bring first-in-class drug for Parkinson’s disease to clinical trials April 7, 2025
Ona Therapeutics Strengthens Leadership Team to Accelerate First-in-Class ADCs into Clinical Development Across Cancer Types February 19, 2025
Peptomyc announces the beginning of a Phase 2 clinical trial of OMO-103 in advanced osteosarcoma January 16, 2025
Accure Therapeutics partner Oculis reached positive phase 2 results for lead neuroprotective therapy January 16, 2025

Passeig de Gràcia, 20 2n 3a
08007 Barcelona
+34 682 300 704
alta@altals.com